ATS Reading List Podcast: Episode 4 - Submassive Pulmonary Embolism
In this episode, we have the pleasure of sitting down with Dr. Parth Rali to discuss two foundational articles on pulmonary embolism treatment. We will discuss the 2002 MAPPETT III trial and 2014 PEITHO trial. Both were published in the New England Journal of Medicine.
Show Notes
If you enjoyed this content, please follow or subscribe and leave us a review!
If you enjoyed this content, please follow or subscribe and leave us a review!
Access the ATS Reading List.
Recommended Reading
- Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347:1143-50.
- Meyer G, Vicaut E, Danays T, et al. PEITHO investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370:1402-11.
- Supplement to: Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370:1402-11. DOI: 10.1056/NEJMoa1302097
- Rali P, Criner GJ. Submassive Pulmonary Embolism. Am J Respir Crit Care Med 2018; 198(5):588-98.
- Chaudhury P, Gadre SK, Schneider E, et al. Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes. Am J Cardiol 2019; 124:1465-69.
- Konstantinides S, Vicaut E, Danays T, et al. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. J Am Coll Cardiol. 2017 Mar, 69 (12) 1536–1544.
